| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 5990 | 2020 |
| Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 2535 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1759 | 2021 |
| Triage of scarce critical care resources in COVID-19 an implementation guide for regional allocation: an expert panel report of the task force for mass critical care and the … RC Maves, J Downar, JR Dichter, JL Hick, A Devereaux, JA Geiling, ... Chest 158 (1), 212-225, 2020 | 311* | 2020 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 141 | 2021 |
| Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial JH Beigel, E Aga, MC Elie-Turenne, J Cho, P Tebas, CL Clark, JP Metcalf, ... The Lancet Respiratory Medicine 7 (11), 941-950, 2019 | 106 | 2019 |
| Campylobacterantimicrobial resistance in Peru: a ten-year observational study S Pollett, C Rocha, R Zerpa, L Patiño, A Valencia, M Camiña, J Guevara, ... BMC infectious diseases 12, 1-7, 2012 | 89 | 2012 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 87 | 2022 |
| Persistent low-level viremia while on antiretroviral therapy is an independent risk factor for virologic failure C Joya, SH Won, C Schofield, T Lalani, RC Maves, K Kronmann, R Deiss, ... Clinical Infectious Diseases 69 (12), 2145-2152, 2019 | 85 | 2019 |
| Antimicrobial Susceptibility of Brucella melitensis Isolates in Peru RC Maves, R Castillo, A Guillen, B Espinosa, R Meza, N Espinoza, ... Antimicrobial Agents and chemotherapy 55 (3), 1279-1281, 2011 | 75 | 2011 |
| Intensive care unit preparedness during pandemics and other biological threats RC Maves, CM Jamros, AG Smith Critical care clinics 35 (4), 609-618, 2019 | 73 | 2019 |
| Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison WS Helton, R Maves, K Wicks, K Johansen Archives of Surgery 136 (1), 17-20, 2001 | 73 | 2001 |
| Genotypic and Phenotypic Characterization of Enterotoxigenic Escherichia coli Strains Isolated from Peruvian Children FP Rivera, TJ Ochoa, RC Maves, M Bernal, AM Medina, R Meza, ... Journal of clinical microbiology 48 (9), 3198-3203, 2010 | 72 | 2010 |
| Unusual presentations of coccidioidomycosis: a case series and review of the literature NF Crum-Cianflone, AA Truett, N Teneza-Mora, RC Maves, HM Chun, ... Medicine 85 (5), 263-277, 2006 | 72 | 2006 |
| Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys RC Maves, RMC Oré, KR Porter, TJ Kochel Vaccine 29 (15), 2691-2696, 2011 | 68 | 2011 |
| Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) study: a randomized controlled trial comparing 3 single-dose antibiotic regimens with loperamide MS Riddle, P Connor, J Fraser, CK Porter, B Swierczewski, EJ Hutley, ... Clinical Infectious Diseases 65 (12), 2008-2017, 2017 | 61 | 2017 |
| Coronavirus disease 2019 pandemic measures: reports from a national survey of 9,120 ICU clinicians R Kleinpell, DM Ferraro, RC Maves, SLK Gill, R Branson, S Greenberg, ... Critical Care Medicine 48 (10), e846-e855, 2020 | 60 | 2020 |
| It takes a village…: contending with drug shortages during disasters LD Burry, JF Barletta, D Williamson, S Kanji, RC Maves, J Dichter, ... Chest 158 (6), 2414-2424, 2020 | 47 | 2020 |
| Detection of Leptospira-specific antibodies using a recombinant antigen-based enzyme-linked immunosorbent assay HW Chen, Z Zhang, ES Halsey, C Guevara, E Canal, E Hall, R Maves, ... The American journal of tropical medicine and hygiene 89 (6), 1088, 2013 | 41 | 2013 |
| Facilitated molecular typing of Shigella isolates using ERIC-PCR M Kosek, PP Yori, RH Gilman, H Vela, MP Olortegui, CB Chavez, ... The American journal of tropical medicine and hygiene 86 (6), 1018, 2012 | 40 | 2012 |
Stephanie A RichardHenry Jackson FoundationVerified email at idcrp.org
